慢性前列腺炎症状指数中文版的研译与性能考评  

Evaluation of a modified Chinese version of the National Institutes of Health-Chronic Prostatitis Symptom Index

作　　者：李一夫[1] 谢辉[2] 杨宇[2] 蔡勇[1] 杨亦荣[1] 

机构地区：[1]温州医学院附属第一医院器官移植中心,325000 [2]温州医学院附属第一医院泌尿外科,325000

出　　处：《中华泌尿外科杂志》2010年第10期710-714,共5页Chinese Journal of Urology

基　　金：温州市科技计划项目（Y20090367）

摘　　要：目的 修订美国国立卫生研究院-慢性前列腺炎症状指数的中文译本（CHN-NIH-CPSI）,并进行性能考评. 方法 采用外国量表跨文化调适的规范程序修订CHN-NIH-CPSI.指导162例慢性前列腺炎患者和97名健康对照者完成该量表.分析量表的可行性、信度、效度和反应度. 结果 量表回收率和完成率均为100%,平均完成时间为（5.2±2.4）min（2～12 min）.基于整个量表奇数条目和偶数条目构成的2个子量表,得出的分半信度系数为0.82;整个量表及3个维度（依次为疼痛、排尿、生存质量）的克朗巴赫α系数依次为0.61、0.71、0.59、0.75;基于95例患者同1天内2次受试的数据,得到整个量表及各维度的重测信度为0.98、0.98、0.98、0.97（P＜0.01）.证实性因子分析显示,拟合优度指数为0.85（Х^2=124.67,P＜0.01）.患者组整个量表及各维度得分分别为23.33±5.91、8.80±4.26、5.30±2.82、9.23±1.90;对照组分别为1.95±1.97、0.37±1.03、0.15±0.58、1.42±1.20;2组间比较差异均有统计学意义（P＜0.01）.95例患者初次受试的整个量表及各维度得分分别为23.53±5.60、9.21±4.04、5.10±2.75、9.21±2.05;治疗4周后分别为19.47±6.36、7.79±3.95、3.58±1.88、8.11±2.50;治疗前后比较差异均有统计学意义（P＜0.01）.结论 CHN-NIH-CPSI具有较好的可行性、信度、效度和反应度,适合我国的语言文化背景,与国际上其他版本的NIH-CPSI有可比性,可被应用于临床和科研.Objective To revise the Chinese version of the National Institutes of Health-Chronic Prostatitis Symptom Index （CHN-NIH-CPSD）, and evaluate its feasibility, reliability, validity and responsiveness. Methods The NIH-CPSI was translated into Chinese according to a standard methodology including forward-backward-forward technique. The CHN-NIH-CPSI was pre-tested in consecutive samples of 162 native-speaking Chinese chronic prostatitis（CP）patients. Ninety-five of 162 filled the index again on the same day and after 4-week therapy. Ninety-seven healthy men were included as evaluated. Results The recovery of the questionnaires was 100% and all the patients filled the index completely. The mean time to complete the questionnaire for the patient group was 5.2±2.4 （range 2 - 12） min. The split-half reliability was 0.82. For the overall index and each subscale, the test-retest reliability was 0.98, 0. 98, 0. 98, 0. 97, respectively（P〈0.01）;and the Cronbach＇s α coefficient was 0. 61,0. 71, 0. 59, 0. 75, respectively. The confirmatory factor analysis showed good construct validity with a goodness of fit index of 0. 85 and a x^2 of 124.67（P〈0. 01）. Of all 162 patients, the scores of the overall index and each subscale were 23. 33±5.91. 8. 80±4.26, 5.30±2.82, 9. 23±1.90, respectively;and those of healthy controls were 1. 95±1.97, 0. 37±1.03, 0. 15±0.58, 1.42± 1.20,respectively. Of the 95 patients, the original scores were 23. 53±5.60, 9.21 ±4.04, 5.10±2.75,9.21 ±2.05, comparing with 19.47±6.36, 7.79±3.95, 3. 58±1.88, 8.11±2.50, the 4 weeks later scores. The group t-test and paired t-test showed good responsiveness. Conclusions The CHN-NIH-CPSI has high feasibility, reliability, validity and responsiveness for testing the patients with CP. It is suitable for Chinese-speaking patients and helpful for cross-cultural comparisons of men with CP in clinical and research settings.

关 键 词：前列腺炎 中文 信度 效度 反应度 

分 类 号：R686[医药卫生—骨科学]